mTOR inhibition enhances delivery and activity of antisense oligonucleotides in uveal melanoma cells
Authors:
- Shanna DewaeleSDShanna Dewaele
- Louis DelhayeLDLouis Delhaye
- Boel De PaepeBoel De Paepe
- Bram BogaertBBBram Bogaert
- Jasper AnckaertJAJasper Anckaert
- Nurten YigitNYNurten Yigit
- Justine NuytensJNJustine Nuytens
- Rudy Van CosterRCRudy Van Coster
- Sven EyckermanSESven Eyckerman
- Koen RaemdonckKRKoen Raemdonck
- Pieter MestdaghPMPieter Mestdagh
Preprint
Abstract
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Due to a lack of effective treatments, patients with metastatic disease have a median survival time of 6-12 months. We recently demonstrated that the SAMMSON long non-coding RNA (lncRNA) is essential for uveal melanoma cell survival and that antisense oligonucleotide (ASO)-mediated silencing of SAMMSON impaired cell viability and tumor growth in vitro and in vivo . By screening a library of 2911 clinical stage compounds, we identified the mTOR inhibitor GDC-0349 to synergize with SAMMSON inhibition in UM. Mechanistic studies revealed that mTOR inhibition enhanced uptake and reduced lysosomal accumulation of lipid complexed SAMMSON ASOs, improving SAMMSON knockdown and further decreasing UM cell viability. We found mTOR inhibition to also enhance target knockdown in other cancer cell lines as well as normal cells when combined with lipid nanoparticle complexed or encapsulated ASOs or small interfering RNAs (siRNAs). Our results are relevant to nucleic acid treatment in general and highlight the potential of mTOR inhibition to enhance ASO and siRNA mediated target knockdown.Keywords
All Related Versions
- Published version: Nucleic Acid Therapeutics, 33 (4), 248.
This publication has 43 references indexed in Scilit:
- A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin AmyloidosisNeurology and Therapy, 2020
- Long non‐coding RNAs in cancer: Another layer of complexityThe Journal of Gene Medicine, 2018
- Methodologies to investigate intracellular barriers for nucleic acid delivery in non-viral gene therapyNano Today, 2018
- Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cellsJournal of Controlled Release, 2018
- Small molecules convey big messages: Boosting non-viral nucleic acid delivery with low molecular weight drugsNano Today, 2017
- Autophagy induction contributes to GDC-0349 resistance in head and neck squamous cell carcinoma (HNSCC) cellsBiochemical and Biophysical Research Communications, 2016
- Effects of Lipofectamine 2000/siRNA Complexes on Autophagy in Hepatoma CellsMolecular Biotechnology, 2011
- Mammalian cell transfection: the present and the futureAnalytical and Bioanalytical Chemistry, 2010
- Establishment and characterization of primary and metastatic uveal melanoma cell linesInternational Journal of Cancer, 1996
- Establishment and characterization of an uveal‐melanoma cell lineInternational Journal of Cancer, 1995